Stock 6598 APPLIED BIOCODE CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News Applied BioCode Corporation

Equities

6598

KYG0488D1051

End-of-day quote Taiwan S.E.
Other stock markets
 23:00:00 27/05/2024 BST 		5-day change 1st Jan Change
20.65 TWD -0.24% Intraday chart for Applied BioCode Corporation -1.20% -18.38%
04-15 Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only CI
03-21 Applied BioCode Announces CEO Changes CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only
BU
Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only
CI
Applied BioCode Announces Retirement of CEO Chris Bernard
BU
Applied BioCode Announces CEO Changes
CI
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Applied BioCode Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Applied BioCode Appoints Industry Veteran Beth Laderman as Chief Scientific Officer
BU
Applied BioCode Appoints Beth Laderman as Chief Scientific Officer
CI
Applied BioCode Corporation Announces the Resignation of Michael Sean Aye as Research and Development Officer
CI
Applied BioCode Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Applied BioCode Corporation Announces the Change of Representative of Institutional Director
CI
Applied BioCode Announces the Launch of the Fungal Panel Assay for Research Use
BU
Applied Biocode Corporation Announces the Launch of the Fungal Panel Assay for Research Use
CI
Applied BioCode Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Applied BioCode Announces Distribution Agreement with Medline Industries
BU
Applied BioCode Corporation Announces Distribution Agreement with Medline Industries
CI
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Applied BioCode Corporation Appoints Liang-Kai Huang as Corporate Governance Officer
CI
Applied BioCode Announces 2022 Q4 and Full year Revenue
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 6598 Stock
  4. News Applied BioCode Corporation